Osage University Partners

Arrakis Therapeutics develops RNA-targeted small-molecule (rSM) medicines, working independently and with partners to create drug candidates aimed at the root causes of disease.

AI & Machine LearningBiotechDeep TechHealthtechCambridge, US

Michael Gilman(Executive Officer, Director)Mark DeLong(CEO)David Neafus(Executive Officer)Russell C. Petter(Executive Officer)

BoardColleen Cuffaro(Director)inAlan E. Walts(Director)in

Co-investorsCanaan PartnersPfizer VenturesAdvent Life SciencesNextech InvestOUP (Osage University Partners)Pfizer Venture Investments+1 more

AssetWatch provides cloud-based asset monitoring software and sensor technology to help manufacturing and industrial facilities prevent unplanned equipment downtime.

Advanced ManufacturingEnterprise SoftwareIoTSaaSWesterville, US

William Zell(Executive Officer, Director)William Ruff(Executive Officer)Robert Lee(Director)Tad Dritz(VP of Development)Jeff Haskett(COO)Brian Graham(Executive Officer, Director)in

Co-investorsCerity Partners VenturesG2 Venture PartnersHarmonic Growth PartnersJobsOhio VenturesMonte Carlo CapitalOUP (Osage University Partners)+3 more

Clarifai develops AI inference technology and compute orchestration software for optimizing model execution at scale.

AI & Machine LearningCloud ComputingData & InfrastructureNew York, US

Matthew Zeiler(Executive Officer, Director)in

BoardAlbert Wenger(Director)in

Co-investorsBright Pixel CapitalCorazon CapitalGV (Google Ventures)Lux CapitalMenlo VenturesNumeta Capital+11 more

DualEntry is an AI-native enterprise resource planning (ERP) platform designed to replace legacy accounting systems for mid-market to enterprise businesses.

AI & Machine LearningEnterprise SoftwareFintechSaaSNew York, US

Santiago Nestares(Co-founder & CEO)inBenedict Dohmen(Co-founder)in

Co-investorsContraryKhosla VenturesLightspeed Venture PartnersGV (Google Ventures)Carya Venture PartnersLudlow Ventures+9 more

BiotechSan Diego, US

Alain Baron(Executive Officer, Director)JeenJoo Kang(Director)Robert Tjian(Director)Marcus Boehm(Executive Officer)

BoardAndrew Schwab(Director)in

Co-investors5AM VenturesAvego BioScience CapitalOUP (Osage University Partners)AbingworthALTITUDE LIFE SCIENCE VENTURESCowen Healthcare Investments+3 more

Everactive develops ultra-low power, self-powered systems-on-chip (SoCs) for Ambient IoT devices that sense, process, and wirelessly transmit data using harvested environmental energy instead of batteries.

HardwareIoTSemiconductorsSan Jose, US

Benton Calhoun(Executive Officer, Director)David Wentzloff(Executive Officer, Director)Brendan R Richardson(Executive Officer, Director)

BoardGeorge Kastendike(Director)Greg Papadopoulos(Director)Jack Busch(Director)

Co-investorsBlue Bear Capital PartnersOUP (Osage University Partners)ABB Technology VenturesNew Enterprise Associates (NEA)

Fortis Therapeutics develops precision cancer therapies that target CD46 proteins on tumor cells while sparing healthy tissue.

BiotechHealthtech

Co-investorsAvalon BioVenturesOUP (Osage University Partners)Vivo CapitalLilly Asia Ventures

Kymeta develops flat-panel satellite antennas and connectivity terminals, including its u5 and u8 product lines, that switch between LEO and GEO networks for mobile land and maritime use.

Defense TechHardwareSpace TechRedmond, US

Marc Stolzman(Executive Officer)Bill Marks(Executive Officer)Keith Cochran(Executive Officer)Manny Mora(President and CEO)Anne(Chief Financial Officer)Ryan(Chief Scientist)

Co-investorsLux CapitalManta Ray VenturesOUP (Osage University Partners)Tectonic Ventures

Picwell operates ALEX, a benefits decision-support platform that combines plan recommendations, enrollment, benefits administration, and year-round guidance for employees.

HR TechInsurTechSaaSPhiladelphia, US

Thomas Baker(Executive Officer, Director)Jonathan Thompson Kolstad(Executive Officer, Director)Robert James Town(Executive Officer, Director)Jay Silverstein(Executive Officer, Director)Anirudh Vemprala(Executive Officer, Director)

BoardKevin Hill(Director)

Co-investorsBlue Venture FundsMassMutual VenturesOUP (Osage University Partners)

Precede Biosciences develops a blood-based diagnostic platform that profiles gene expression from cell-free DNA to reveal disease biology at the transcriptional level for drug developers and clinical trials.

AI & Machine LearningBiotechDigital HealthBoston, US

Rehan Verjee(Co-Founder, Chief Executive Officer, Board Director)Sylvan Baca(Co-Founder; Assistant Professor of Medicine, Dana-Farber Cancer Institute)Toni Choueiri(Co-Founder; Director, Lank Center for GU Oncology, Dana-Farber Cancer Institute)Matthew Freedman(Co-Founder; Professor of Medicine, Dana-Farber Cancer Institute)

Co-investorsIllumina Ventures5AM VenturesOUP (Osage University Partners)Lilly Asia Ventures

BiotechSouth San Francisco, US

Grace Lu(Executive Officer)James Christensen(Executive Officer, Director)Charles Baum(Executive Officer, Director)

BoardMichael Goller(Director)Reid Huber(Director)inPeter Thompson(Director)

Co-investorsRA CapitalEcoR1 CapitalNovo HoldingsOrbiMedThird Rock Ventures

Tessera Therapeutics develops Gene Writing, a genome engineering technology platform designed to make permanent alterations to the human genome for treating diseases.

BiotechDigital HealthMedical Devices

Co-investorsArtis VenturesFlagship PioneeringMarch Capital PartnersOMX VenturesSoftBank Vision FundSolari Capital+4 more

Tessera provides a multi-agent AI platform for enterprise system modernization, automating processes across ERP, CRM, HCM, and finance systems with governed execution.

AI & Machine LearningEnterprise SoftwareSaaS

Kabir Nagrecha(Chief Executive Officer)inMing Chang(Chief Operating Officer)inAnirudh Sriram(Chief Technology Officer)inPrakash Gupta(Chief Revenue Officer)in

Co-investorsAndreessen HorowitzFoundation CapitalMyriad Venture PartnersOUP (Osage University Partners)